Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of Aspirin Use With Cancer Incidence and Survival Among Older Adults in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Holli A. Loomans‐Kropp, Paul F. Pinsky, Asad Umar
JAMA Network Open (2021) Vol. 4, Iss. 1, pp. e2032072-e2032072
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Analysis of Body Mass Index in Early and Middle Adulthood and Estimated Risk of Gastrointestinal Cancer
Holli A. Loomans‐Kropp, Asad Umar
JAMA Network Open (2023) Vol. 6, Iss. 5, pp. e2310002-e2310002
Open Access | Times Cited: 17
Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies
Thi Ngoc Mai Nguyen, Li‐Ju Chen, Kira Trares, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Platelets in the tumor microenvironment and their biological effects on cancer hallmarks
Lilan Chen, Chunyan Zhu, Fan Pan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 14
Using aspirin to prevent and treat cancer
Lenard M. Lichtenberger
Inflammopharmacology (2023) Vol. 32, Iss. 1, pp. 903-908
Closed Access | Times Cited: 10
Aspirin in Cancer Therapy: Pharmacology and Nanotechnology Advances
Umm E. Laila, Z Zhao, Huai Liu, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2327-2365
Open Access
The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC
Giulia Peduzzi, Lívia Archibugi, Riccardo Farinella, et al.
Seminars in Cancer Biology (2025)
Open Access
Targeting cancer-related inflammation with non-steroidal anti-inflammatory drugs: Perspectives in pharmacogenomics
Hongjin Lai, Yi Liu, Juan Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 16
Coagulation Factor Expression and Composition of Arterial Thrombi in Cancer-Associated Stroke
Joonsang Yoo, Il Kwon, Sungeun Kim, et al.
Stroke (2023) Vol. 54, Iss. 12, pp. 2981-2989
Closed Access | Times Cited: 9
Remotely controlled electro-responsive on-demand nanotherapy based on amine-modified graphene oxide for synergistic dual drug delivery
Dibakar Sahoo, Tapas Mitra, Koushik Chakraborty, et al.
Materials Today Chemistry (2022) Vol. 25, pp. 100987-100987
Closed Access | Times Cited: 12
Drug repurposing for cancer
Juni Banerjee, Anand Krishna Tiwari, Shuvomoy Banerjee
Progress in molecular biology and translational science (2024), pp. 123-150
Closed Access | Times Cited: 2
Antiplatelet medications and risk of intracranial hemorrhage in patients with metastatic brain tumors
Eric J Miller, Rushad Patell, Erik J. Uhlmann, et al.
Blood Advances (2022) Vol. 6, Iss. 5, pp. 1559-1565
Open Access | Times Cited: 11
Survival Analysis of 1140 Patients with Biliary Cancer and Benefit from Concurrent Renin-Angiotensin Antagonists, Statins, or Aspirin with Systemic Therapy
Valerie Gunchick, Rachel L McDevitt, Elizabeth Choi, et al.
The Oncologist (2023) Vol. 28, Iss. 6, pp. 531-541
Open Access | Times Cited: 5
Use of Nonsteroidal Anti-Inflammatory Drugs and Pancreatic Cancer Risk in the Women’s Health Initiative
Theodore M. Brasky, Leah R. Jager, Alison M. Newton, et al.
Cancer Epidemiology Biomarkers & Prevention (2024) Vol. 33, Iss. 9, pp. 1203-1210
Closed Access | Times Cited: 1
Does Aspirin Use Reduce the Risk for Ovarian Cancer?
John P. Micha, Mark A. Rettenmaier, Randy Bohart, et al.
Cancer Investigation (2024) Vol. 42, Iss. 7, pp. 643-646
Closed Access | Times Cited: 1
Aspirin Use and Survival Among Patients With Breast Cancer: A Systematic Review and Meta-Analysis
A Baker, Christiana Kartsonaki
The Oncologist (2023) Vol. 29, Iss. 1, pp. e1-e14
Open Access | Times Cited: 3
Three pandemics at once: Noninfectious (cancer), infectious (COVID-19), and behavioral (hypokinesia)
Aleksey Golubev, T. Yu. Semiglazova, Valeriya Klyuge, et al.
Voprosy Onkologii (2021) Vol. 67, Iss. 2, pp. 163-180
Open Access | Times Cited: 6
Can Aspirin Use Be Associated With the Risk or Prognosis of Bladder Cancer? A Case-Control Study and Meta-analytic Assessment
Bo Fan, Alradhi Mohammed, Yuanbin Huang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 5
Metastatic Breast Cancer Recurrence after Bone Fractures
Nadia Obi, Stefan Werner, Frank Thelen, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 601-601
Open Access | Times Cited: 3
Anesthesia-related intervention for long-term survival and cancer recurrence following breast cancer surgery: A systematic review of prospective studies
Yuecheng Yang, Yunkui Zhang, Youhong Tang, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0296158-e0296158
Open Access | Times Cited: 1
Microtubule interacting and trafficking domain containing 1 deficiency leads to poor survival via tissue factor-mediated coagulation in bladder cancer
Yuanbin Chen, Wei Jiao, Yonghua Wang, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 7, pp. 1956-1972
Closed Access
The potential causal association between aspirin consumption and the risk of prostate cancer incidence: a Mendelian randomization analysis
Wenliang Zhu, Xiaomin Lai, Huajian Lai, et al.
Research Square (Research Square) (2024)
Open Access
Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies
Thi Ngoc Mai Nguyen, Li‐Ju Chen, Kira Trares, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Home-built environment interventions and inflammation biomarkers: a systematic review and meta-analysis protocol
Eva Garrosa Hernández, E Chrysikou, Larissa Nekhlyudov, et al.
BJGP Open (2022) Vol. 6, Iss. 4, pp. BJGPO.2022.0104-BJGPO.2022.0104
Open Access | Times Cited: 1
Targeting Platelet Activation Pathways to Limit Tumour Progression: Current State of Affairs
Kutlwano Rekgopetswe Xulu, Tanya N. Augustine
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1532-1532
Open Access | Times Cited: 1
Influence of postdiagnostic aspirin use on clinical outcomes of women with breast cancer: a meta-analysis
Chuanfeng Wu, Minmin Hu, Shuangling Zhang, et al.
Women & Health (2023) Vol. 64, Iss. 2, pp. 94-108
Closed Access
Page 1 - Next Page

Scroll to top